52533-65-0

Basic information

• Product Name: Phosphonium, [5-[(methylsulfonyl)amino]-5-oxopentyl]triphenyl-, bromide
• CAS NO: 52533-65-0
• Molecular Formula: C24H27NO3PS.Br
• Molecular Weight: 520.427
• Mol File: 52533-65-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Phosphonium, [5-[(methylsulfonyl)amino]-5-oxopentyl]triphenyl-, bromide(CAS DataBase Reference)
• NIST Chemistry Reference: Phosphonium, [5-[(methylsulfonyl)amino]-5-oxopentyl]triphenyl-, bromide(52533-65-0)
• EPA Substance Registry System: Phosphonium, [5-[(methylsulfonyl)amino]-5-oxopentyl]triphenyl-, bromide(52533-65-0)

Safety Data

• Hazardous Substances Data: 52533-65-0(Hazardous Substances Data)

Upstream product

• 52533-64-9 N-Methansulfonyl-5-brom-valeramid 
• 603-35-0 triphenylphosphine 
• 4509-90-4 5-bromovaleroyl chloride 

Downstream Products

• 65905-40-0 N-{(Z)-7-[(1R,2R)-2-((E)-(S)-3-Hydroxy-5-phenyl-pent-1-enyl)-5-oxo-cyclopentyl]-hept-5-enoyl}-methanesulfonamide 
• 127718-29-0 N-{(Z)-7-[(1R,2R,3R,5S)-5-Hydroxy-2-((E)-(R)-4-phenoxy-3-trimethylsilanyloxy-but-1-enyl)-3-trimethylsilanyloxy-cyclopentyl]-hept-5-enoyl}-methanesulfonamide 
• 79172-00-2 N-(methanesulfonyl)-16-phenox-ω-tetranor-PGF_2α-carboxamide 
• 60325-46-4 Sulprostone 
• 79124-60-0 N-[5-(Triphenyl-λ⁵-phosphanylidene)-pentanoyl]-methanesulfonamide 
• 64282-81-1 N-{(Z)-7-[(1R,2R,3R,5S)-5-Hydroxy-2-[(E)-(R)-4-phenoxy-3-(tetrahydro-pyran-2-yloxy)-but-1-enyl]-3-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-hept-5-enoyl}-methanesulfonamide 
• 69590-40-5 N-{(Z)-7-[(1R,2R,3R,5S)-5-Hydroxy-2-[(E)-(S)-5-phenyl-3-(tetrahydro-pyran-2-yloxy)-pent-1-enyl]-3-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-hept-5-enoyl}-methanesulfonamide 
• 65905-37-5 N-{(Z)-7-[(1R,2S,5R)-2-Hydroxy-5-((E)-(S)-3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-hept-5-enoyl}-methanesulfonamide 

Relevant articles and documents

Difluoroprostaglandin derivatives and their use

A fluorine-containing prostaglandin derivative of the formula (1) (or a salt thereof) and a medicine containing it, particularly, a preventive or therapeutic medicine for an eye disease: STR1 wherein A is a vinylene group or the like, R1 is an

Substituted ω-pentanorprostaglandins

Substituted novel ω-pentanorprostaglandins and various novel intermediates and reagents used in their preparation.